European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.52% to 1,411.57 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (EDAP), which rose 5.9% and 4% respectively. They were followed by software firm SAP (SAP) and telecommunications company VEON (VEON), which were up 2.7% and 2%.
The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and Evaxion Biotech (EVAX), which fell 3.4% and 2.7% respectively. They were followed by oil and gas companies Eni (E) and TotalEnergies (TTE), which dropped 2.4% and 2.1% respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and cruise line operator Carnival (CUK), which increased 5.2% and 3.9% respectively. They were followed by Adaptimmune Therapeutics (ADAP), which advanced 3.1%.
The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and mining company BHP Group (BHP), which lost 4.9% and 4.3% respectively. They were followed by insurance company Prudential (PUK) and financial services company HSBC (HSBC), which were down about 3.9% each.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。